Aortic Valve Replacement with a Conventional Stented Bioprosthesis versus Sutureless Bioprosthesis: a Study of 763 Patients
| Autor: | Simon Ledingham, Thasee Pillay, Stephan Schueler, Syed Saleem Mujtaba, Asif Raza Shah, Stephen Clark |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
Male
Heart Valve Prosthesis/Utilization lcsh:Diseases of the circulatory (Cardiovascular) system Time Factors Bypass grafting medicine.medical_treatment 030204 cardiovascular system & hematology 0302 clinical medicine Aortic valve replacement Postoperative Period 030212 general & internal medicine Aged 80 and over Heart Valve Prosthesis Implantation Cardiopulmonary Bypass Aortic Valve/Surgery Effective orifice area Atrial fibrillation General Medicine Middle Aged Constriction Sutureless Surgical Procedures Treatment Outcome medicine.anatomical_structure Aortic Valve Heart Valve Prosthesis Original Article Female Cardiology and Cardiovascular Medicine Artery Adult medicine.medical_specialty lcsh:Surgery Prosthesis Design Transcatheter Aortic Valve Replacement 03 medical and health sciences medicine Humans Aged Retrospective Studies Bioprosthesis business.industry Reproducibility of Results Retrospective cohort study Aortic Valve Stenosis lcsh:RD1-811 A300 medicine.disease Sternotomy Surgery lcsh:RC666-701 Median sternotomy business |
| Zdroj: | Brazilian Journal of Cardiovascular Surgery, Vol 33, Iss 2, Pp 122-128 Brazilian Journal of Cardiovascular Surgery v.33 n.2 2018 Brazilian Journal of Cardiovascular Surgery Sociedade Brasileira de Cirurgia Cardiovascular (SBCCV) instacron:SBCCV Brazilian Journal of Cardiovascular Surgery, Volume: 33, Issue: 2, Pages: 122-128, Published: APR 2018 |
| ISSN: | 1678-9741 |
| Popis: | Objective: The aim of this retrospective study was to compare early postoperative outcomes after aortic valve replacement (AVR) with sutureless bioprostheses and conventional stented bioprostheses implanted through median sternotomy.\ud \ud Methods: From January 2011 to December 2016, 763 patients underwent aortic valve replacement with bioprostheses; of these, 139 received a Perceval S sutureless valve (Group A) and 624 received a Perimount Magna Ease valve (Group B). These groups were further divided into A1 (isolated Perceval AVR), A2 (Perceval AVR with coronary artery bypass grafting [CABG]), B1 (isolated conventional stented bioprosthesis), and B2 (conventional stented bioprosthesis + CABG).\ud \ud Results: Patients in Group A were older (mean 74 years vs. 71 years; P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|